PAA 2.86% 18.0¢ pharmaust limited

Hi all,News article today....

  1. 1,066 Posts.
    lightbulb Created with Sketch. 2158
    Hi all,

    News article today.

    https://www.abc.net.au/news/2024-08-14/john-hutchins-shares-his-experience-of-epidermolysis-bullosa/104219348


    Recent studies have identified mTOR inhibitors as promising therapies for epidermolysis bullosa simplex (EBS). Transcriptomic analyses revealed that mTOR inhibitors, such as sirolimus, can significantly oppose the gene expression signature associated with EBS blisters. Pilot studies using topical sirolimus showed marked clinical improvement in patients, reducing symptoms like painful plantar keratoderma. The mTOR pathway's involvement suggests that mTOR inhibitors could be effective in managing EBS by downregulating defective keratin expression and reducing cell proliferation, thus alleviating pain and itch.

    Another prospective treatment, makes over 70 I believe.


    Kpax
 
watchlist Created with Sketch. Add PAA (ASX) to my watchlist
(20min delay)
Last
18.0¢
Change
0.005(2.86%)
Mkt cap ! $87.55M
Open High Low Value Volume
18.0¢ 18.0¢ 17.5¢ $36.85K 205.3K

Buyers (Bids)

No. Vol. Price($)
6 162181 17.5¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 412357 6
View Market Depth
Last trade - 16.10pm 12/09/2024 (20 minute delay) ?
PAA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.